Clinical Trials Browser

Phase 1 × OTHER_GOV × Lymphoma, T-Cell, Peripheral × Clear all

NCT05083208 2025-12-02

PI3Kδ Inhibitor Parsaclisib Combined With Chidamide for the Treatment of Relapsed/Refractory Peripheral T-cell Lymphoma

Phase 1 Terminated

Lymphoma, T-Cell, Peripheral

NCT05900089 2023-06-12

Efficacy and Safety of SHR0302 in Patients With Relapsed/Refractory Peripheral T/NK Cell Lymphoma

Phase 1 Unknown

Lymphoma, T-Cell, Peripheral